|
ZC3H15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.54163357027437E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.65170046715491E-10 |
| Normal-vs-Stage2 |
4.53199999972398E-07 |
| Normal-vs-Stage3 |
1.01174624234091E-12 |
| Normal-vs-Stage4 |
9.09361475009973E-12 |
| Stage1-vs-Stage2 |
3.608600E-01 |
| Stage1-vs-Stage3 |
1.114240E-02 |
| Stage1-vs-Stage4 |
5.702900E-03 |
| Stage2-vs-Stage3 |
4.079200E-01 |
| Stage2-vs-Stage4 |
2.930800E-01 |
| Stage3-vs-Stage4 |
6.985800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.9284573937739E-13 |
| Normal-vs-AfricanAmerican |
1.842190E-04 |
| Normal-vs-Asian |
1.62770000000645E-06 |
| Caucasian-vs-AfricanAmerican |
4.348000E-01 |
| Caucasian-vs-Asian |
4.084800E-01 |
| AfricanAmerican-vs-Asian |
8.948000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.8118950784185E-11 |
| Normal-vs-Female |
1.47709622311254E-11 |
| Male-vs-Female |
2.889000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.55570003732709E-09 |
| Normal-vs-Age(41-60Yrs) |
4.15201206749316E-12 |
| Normal-vs-Age(61-80Yrs) |
2.33729702259211E-11 |
| Normal-vs-Age(81-100Yrs) |
3.738100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.077240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.266300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.087400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.344200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.838000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.145000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.144030E-01 |
| Classical-VS-Follicular |
5.289200E-01 |
| Classical-VS-Other |
4.308600E-01 |
| Classical-VS-Normal |
2.21049845094967E-11 |
| Tall-VS-Follicular |
3.292800E-01 |
| Tall-VS-Other |
9.867400E-01 |
| Tall-VS-Normal |
2.10270000300383E-08 |
| Follicular-VS-Other |
6.987400E-01 |
| Follicular-VS-Normal |
3.31810000031574E-07 |
| Other-VS-Normal |
2.156500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.57049953439537E-11 |
| Normal-vs-N1 |
4.95010032963705E-10 |
| N0-vs-N1 |
3.110600E-01 |
|
|
